Article Information
History
- September 27, 2019.
Article Versions
- Version 1 (September 23, 2019 - 06:20).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Joni Merisaari1,2,
- Oxana V. Denisova1,
- Milena Doroszko3,
- Vadim Le Joncour4,
- Patrik Johansson3,
- William P.J. Leenders5,
- David B. Kastrinsky6,7,
- Nilesh Zaware6,
- Goutham Narla8,
- Pirjo Laakkonen4,9,
- Sven Nelander3,
- Michael Ohlmeyer6,10 and
- Jukka Westermarck1,2,#
- 1Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland
- 2Institute of Biomedicine, University of Turku, Turku, Finland
- 3Department of Immunology Genetics and Pathology, Uppsala University, Uppsala, Sweden
- 4Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland
- 5Radboud Institute for Molecular Life Sciences, Department of Biochemistry, Nijmegen, The Netherlands
- 6Icahn School of Medicine at Mount Sinai, New York, New York, USA
- 7Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA
- 8Department of Internal Medicine, Division of Genetic Medicine, University of Michigan, Ann Arbor, MI, USA
- 9Helsinki Institute of Life Science – HiLIFE, Laboratory Animal Centre, University of Helsinki, Helsinki, Finland
- 10Atux Iskay LLC, Plainsboro, NJ, USA
- ↵#Corresponding author: Jukka Westermarck, tel. +358-29-450 2880, jukka.westermarck{at}bioscience.fi